Literature DB >> 20304181

Anxiety levels observed in candidates for liver transplantation.

G R Santos1, I F S F Boin, M I W Pereira, T C M P Bonato, R C M A Silva, R S B Stucchi, R F da Silva.   

Abstract

INTRODUCTION: Anxiety can be considered an emotional state that does not present itself at the same intensity in all patients, and can be classified into 3 levels: mild, moderate, and severe. The patient, upon entering the waiting list for transplantation, reflects on the decision taken, which leaves him constantly anxious about the idea of possible death.
OBJECTIVE: This study had the aim of evaluating the degree of anxiety observed in orthotopic liver transplantation (OLT) candidates and whether there was a correlation between anxiety and etiologic diagnosis.
METHODS: This study was a prospective study where the patients underwent psychological evaluation by Beck Anxiety Inventory (BAI). The anxiety level was minimal, mild, moderate, or severe. The Model for End-Stage Liver Disease (MELD) score and etiology were recorded.
RESULTS: The level of anxiety found were as follows: 55% minimal, 27% mild, 12% moderate, and 7% severe. The correlation between level of anxiety and etiologic diagnosis showed that 71% of patients with alcoholic cirrhosis and 60% of those with liver cancer showed a minimal degree of anxiety and 27% of patients with autoimmune cirrhosis had severe anxiety.
CONCLUSION: We found that in patients with autoimmune hepatitis, the degree of anxiety was more pronounced. It is believed that the absence of physical symptoms is an important factor when observing anxiety in OLT candidates. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304181     DOI: 10.1016/j.transproceed.2010.01.009

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

2.  Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.

Authors:  Lissi Hansen; Karen S Lyons; Nathan F Dieckmann; Michael F Chang; Shirin Hiatt; Emma Solanki; Christopher S Lee
Journal:  Res Nurs Health       Date:  2017-06-30       Impact factor: 2.228

Review 3.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

4.  Psychiatric Comorbidity, Health-Related Quality of Life, and Mental Health Service Utilization Among Patients Awaiting Liver Transplant.

Authors:  Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon
Journal:  J Pain Symptom Manage       Date:  2018-03-08       Impact factor: 3.612

5.  Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Authors:  Christian Benzing; Nicco Krezdorn; Julia Förster; Andreas Hinz; Felix Krenzien; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

Review 6.  Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review.

Authors:  Sara Vieira Silva; Elga Freire; Helena Pessegueiro Miranda
Journal:  GE Port J Gastroenterol       Date:  2020-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.